Fatal orthotopic liver transplant organ rejection induced by a checkpoint inhibitor in two patients with refractory, metastatic hepatocellular carcinoma

Immune analysis of fibrolamellar hepatocellular carcinoma.

(2017) Mehmet Akce et al.   JOURNAL OF CLINICAL ONCOLOGY

Preserved Renal-Allograft Function and the PD-1 Pathway Inhibitor Nivolumab

(2017) Richard Barnett et al.   NEW ENGLAND JOURNAL OF MEDICINE

Complete Response of Hepatocellular Carcinoma in a Patient With End-stage Liver Disease treated With Nivolumab: Whishful thinking or Possible?

(2016) Joerg Trojan et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Use of the PD-1 Pathway Inhibitor Nivolumab in a Renal Transplant Patient With Malignancy

(2016) C. L. Boils et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Checkpoint Inhibitors in Kidney Transplant Recipients and the Potential Risk of Rejection

(2016) T. Alhamad et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Acute renal allograft rejection after immune checkpoint inhibitor therapy for metastatic melanoma

(2016) L. Spain et al.   ANNALS OF ONCOLOGY

PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation

(2016) J C Albring et al.   BONE MARROW TRANSPLANTATION

Fatal GvHD induced by PD-1 inhibitor pembrolizumab in a patient with Hodgkin’s lymphoma

(2016) A K Singh et al.   BONE MARROW TRANSPLANTATION

Checkpoint inhibitors in chronic kidney failure and an organ transplant recipient

(2016) Saskia Herz et al.   EUROPEAN JOURNAL OF CANCER

Management of adverse events related to new cancer immunotherapy (immune checkpoint inhibitors)

(2016) Jack M Bourke et al.   MEDICAL JOURNAL OF AUSTRALIA

Tumor Regression and Allograft Rejection after Administration of Anti–PD-1

(2016) Evan J. Lipson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antitumor activity of nivolumab on hemodialysis after renal allograft rejection

(2016) Michael Ong et al.   Journal for ImmunoTherapy of Cancer

B Cells, Antibodies, and More

(2015) W. Hoffman et al.   Clinical Journal of the American Society of Nephrology

Administration of Ipilimumab to a Liver Transplant Recipient With Unresectable Metastatic Melanoma

(2015) Harsha A. Ranganath et al.   JOURNAL OF IMMUNOTHERAPY

Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation

(2015) Rita E Morales et al.   Journal for ImmunoTherapy of Cancer

Essential Role of PDL1 Expression on Nonhematopoietic Donor Cells in Acquired Tolerance to Vascularized Cardiac Allografts

(2011) L. V. Riella et al.   AMERICAN JOURNAL OF TRANSPLANTATION